id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-P-0062-0004,FDA,FDA-2005-P-0062,Letter from FDA CFSAN to U S Public Interest Research Group,Other,Letter(s),2006-05-25T04:00:00Z,2006,5,,,2025-04-24T13:38:09Z,,0,0,090000648043f11e
FDA-2005-P-0062-0003,FDA,FDA-2005-P-0062,Letter from FDA CFSAN to U S Public Interest Research Group,Other,Letter(s),2006-05-25T04:00:00Z,2006,5,,,2025-04-24T13:36:27Z,,0,0,090000648043f11c